Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Summaries of opinion Remove Summaries of opinion filter Paediatric investigation plans Remove Paediatric investigation plans filter Orphan designations Remove Orphan designations filter Referrals Remove Referrals filter

Product number

Date of opinion

From:

To:

Decision date

From:

To:

Referral name

Referral status

European Commission final decision (3) Apply European Commission final decision filter Opinion provided by Committee for Medicinal Products for Human Use (1) Apply Opinion provided by Committee for Medicinal Products for Human Use filter

Referral safety status

Yes (1) Apply Yes filter

Referral type

Article 20 procedures (3) Apply Article 20 procedures filter Article 31 referrals (1) Apply Article 31 referrals filter

Referral reference number

Referral decision making model

PRAC-CAT-CHMP-EC (1) Apply PRAC-CAT-CHMP-EC filter PRAC-CHMP-EC (1) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally and nationally authorised products (mixed) Remove Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) Remove Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (2) Apply Risk minimisation measures filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Medicine type

Conditional approval Remove Conditional approval filter Exceptional circumstances Remove Exceptional circumstances filter Orphan medicine Remove Orphan medicine filter Accelerated assessment (3) Apply Accelerated assessment filter Additional monitoring (16) Apply Additional monitoring filter Generic (3) Apply Generic filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

4 results

Remove all filtersRemove all filters

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter Paediatric investigation plans Remove Paediatric investigation plans filter Orphan designations Remove Orphan designations filter Summaries of opinion Remove Summaries of opinion filter

Medicine type Exceptional circumstances Remove Exceptional circumstances filter Orphan medicine Remove Orphan medicine filter Conditional approval Remove Conditional approval filter

Referral authorisation model Centrally and nationally authorised products (mixed) Remove Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) Remove Centrally authorised product(s) filter

Categories Human Remove Human filter

Sort by

List item

Referral: Adakveo (updated)

crizanlizumab, associated names: Adakveo, Article 20 procedures
Status: Opinion provided by Committee for Medicinal Products for Human Use, opinion/position date: 25/05/2023, Last updated: 26/05/2023
List item

Referral: Zynteglo

betibeglogene autotemcel, associated names: Zynteglo, Article 20 procedures
Status: European Commission final decision, opinion/position date: 22/07/2021, EC decision date: 16/09/2021, Last updated: 08/07/2022
List item

Referral: Lartruvo

olaratumab, associated names: Lartruvo, Article 20 procedures
Status: European Commission final decision, opinion/position date: 31/01/2019, EC decision date: 19/07/2019, Last updated: 22/08/2019
List item

Referral: Factor VIII

associated names: Iblias, Elocta, Kovaltry, Nuwiq, Obizur, NovoEight, Voncento, ReFacto AF, Kogenate Bayer, Helixate NexGen, Advate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/09/2017, EC decision date: 10/10/2017, Last updated: 05/12/2017

4 results

Referral: Adakveo (updated)

Referral: Zynteglo

Referral: Lartruvo

Referral: Factor VIII